PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

News

UK’s MRC invests in research into hard-to-treat cancers

UK Research and Innovation’s (UKRI) Medical Research Council (MRC) is investing £2 million to support research into cancers with poor [...]

18 Sep 2023
Read full article

Government funds to grow UK life sciences workforce and upgrade science facility

As part of its £650m ‘Life Sci for Growth’ scheme to boost the life sciences sector and the wider economy, [...]

13 Sep 2023
Read full article

UK rejoins Horizon Europe

Britain’s life science community is celebrating the country’s return to the EU Horizon Europe research programme, which was announced on [...]

11 Sep 2023
Read full article

Public and HCP trust in UK pharma industry maintained

The third annual Pharma Reputation Index, commissioned by the Association of the British Pharmaceutical Industry (ABPI), has found that the [...]

7 Sep 2023
Read full article

MHRA consults on ending EC Decision Reliance Procedure

The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting feedback on plans to end use of the European Commission [...]

4 Sep 2023
Read full article

Still no UK-EU agreement on Horizon Europe

Roadblocks from the EU, and the UK government’s determination to get a ‘fair settlement’ on associate membership, are harming international [...]

16 Aug 2023
Read full article

Clarification on continuation of CE marking in UK

The UK’s Department for Business and Trade (DBT) has announced an indefinite extension to the use of CE marking for [...]

7 Aug 2023
Read full article

Calling biotech startups

Whether you are heading off to the beach this summer or relaxing at home, this quieter period is a good [...]

2 Aug 2023
Read full article

MHRA publishes annual report for 2022-2023

The UK Medicines and Healthcare products Regulatory Agency’s (MHRA) annual report and accounts for 2022-2023 was printed on 19 July [...]

31 Jul 2023
Read full article

UK government consults on draft legislation on merged R&D tax relief

Draft legislation has been published by the UK government on a proposed merged R&D tax relief scheme. If implemented, the [...]

25 Jul 2023
Read full article

Why we need Medical Affairs 3.0

New biotechs and small pharma companies find it hard to take their products from discovery to market because of a [...]

24 Jul 2023
Read full article

Pharma organisations tussle over VPAS negotiations

A High Court judgment on a judicial review brought by the British Generic Manufacturers Association (BGMA) has dismissed the organisation’s [...]

20 Jul 2023
Read full article

International investment in UK life sciences plummets

Figures from the ninth annual life sciences competitiveness indicators (LSCIs) report show that in 2022 the UK saw a substantial [...]

19 Jul 2023
Read full article

MHRA announces corporate plan for 2023-2026

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has published its corporate plan for the next three years, featuring [...]

17 Jul 2023
Read full article

NIHR and MRC launch UK Rare Disease Research Platform

The National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC) are investing £14 million in [...]

13 Jul 2023
Read full article

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #drugapprovals #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HorizonEurope #HTA #innovation #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicinesaccess #medtech #mentalhealth #mhra #NHS #NICE #patients #pharmaregulation #pre-eclampsia #R&D #rarediseases #regulation #regulatory #research #startups #UKgovernment #ukpharma #ukregulation #VPAS AI Biotech COVID-19 Healthcare medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital